Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;25:764-768

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marumo, T.
Right arrow Articles by Saruta, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marumo, T.
Right arrow Articles by Saruta, T.

(Hypertension. 1995;25:764-768.)
© 1995 American Heart Association, Inc.


Articles

Cyclosporin A Inhibits Nitric Oxide Synthase Induction in Vascular Smooth Muscle Cells

Takeshi Marumo; Toshio Nakaki; Keiichi Hishikawa; Hiromichi Suzuki; Ryuichi Kato; Takao Saruta

From the Departments of Internal Medicine (T.M., K.H., H.S., T.S.) and Pharmacology (T.M., T.N., R.K.), Keio University School of Medicine, Tokyo, Japan.

Correspondence to Toshio Nakaki, MD, PhD, Department of Pharmacology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan.

Abstract The effect of cyclosporin A on induction of nitric oxide synthase in rat aortic smooth muscle cells was examined. A combination of interleukin-1{alpha} (100 U/mL) and tumor necrosis factor-{alpha} (5000 U/mL) induced accumulation of nitrite/nitrate, the stable end products of nitric oxide, in culture media within 48 hours. Cyclosporin A inhibited this nitrite/nitrate accumulation in a concentration-dependent manner with an IC50 of 4x10-7 mol/L when applied simultaneously with the cytokines. The expression of inducible nitric oxide synthase messenger RNA (mRNA) induced by the combination of interleukin-1{alpha} and tumor necrosis factor–{alpha} was inhibited by the cyclosporin A cotreatment. Cyclosporin A did not decrease inducible nitric oxide synthase mRNA stability in the presence of transcription inhibitor actinomycin D (5 µg/mL). Induction of nitrite/nitrate production by the combination of tumor necrosis factor–{alpha} and bacterial lipopolysaccharide or that of interleukin-1{alpha} and interferon gamma (100 U/mL) was also inhibited by cyclosporin A cotreatment. Another inhibitor of calcineurin, FK506 (up to 10-6 mol/L), had no effect on the induction of nitrite/nitrate production, suggesting the possibility that the inhibitory effect of cyclosporin A may be exerted by means of a novel pathway other than inhibition of calcineurin. These results indicate that cyclosporin A inhibits inducible nitric oxide synthase induction at the mRNA level and that inducible nitric oxide synthase in vascular smooth muscle cells can be a target for cyclosporin A, providing a possible mechanism for the interference of the drug with the balance of vasoactive substances.


Key Words: cyclosporine • nitric oxide • interleukin-1 • tumor necrosis factor • interferon type II




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
J. M. Foster, P. K. Carmines, and J. S. Pollock
PP2B-dependent NO production in the medullary thick ascending limb during diabetes
Am J Physiol Renal Physiol, August 1, 2009; 297(2): F471 - F480.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
B.-K. Chen, C.-C. Huang, W.-C. Chang, Y.-J. Chen, U. Kikkawa, K.-i. Nakahama, I. Morita, and W.-C. Chang
PP2B-mediated Dephosphorylation of c-Jun C Terminus Regulates Phorbol Ester-induced c-Jun/Sp1 Interaction in A431 Cells
Mol. Biol. Cell, March 1, 2007; 18(3): 1118 - 1127.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Sano, S. Itami, and K. Yoshikawa
Treatment of Primary Erythromelalgia with Cyclosporine
N. Engl. J. Med., August 21, 2003; 349(8): 816 - 817.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. LIGTENBERG, R. J. HENÉ, P. J. BLANKESTIJN, and H. A. KOOMANS
Cardiovascular Risk Factors in Renal Transplant Patients: Cyclosporin A Versus Tacrolimus
J. Am. Soc. Nephrol., February 1, 2001; 12(2): 368 - 373.
[Abstract] [Full Text]


Home page
Nephrol Dial TransplantHome page
J. Lee, S. W. Kim, H. Kook, D. G. Kang, N. H. Kim, and K. C. Choi
Effects of L-arginine on cyclosporin-induced alterations of vascular NO/cGMP generation
Nephrol. Dial. Transplant., November 1, 1999; 14(11): 2634 - 2638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Tian and M. Karin
Stimulation of Elk1 Transcriptional Activity by Mitogen-activated Protein Kinases Is Negatively Regulated by Protein Phosphatase 2B (Calcineurin)
J. Biol. Chem., May 21, 1999; 274(21): 15173 - 15180.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Takeda, I. Miyamori, K. Furukawa, S. Inaba, and H. Mabuchi
Mechanisms of FK 506–Induced Hypertension in the Rat
Hypertension, January 1, 1999; 33(1): 130 - 136.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N. A. Bobadilla, G. Gamba, E. Tapia, R. Garcia-Torres, A. Bolio, P. Lopez-Zetina, and J. Herrera-Acosta
Role of NO in cyclosporin nephrotoxicity: effects of chronic NO inhibition and NO synthases gene expression
Am J Physiol Renal Physiol, April 1, 1998; 274(4): F791 - F798.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Aiko, E. M. Conner, J. A. Fuseler, and M. B. Grisham
Effects of Cyclosporine or FK506 in Chronic Colitis
J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 1075 - 1084.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
T. Obata, A. Kashiwagi, H. Maegawa, Y. Nishio, S. Ugi, H. Hidaka, and R. Kikkawa
Insulin Signaling and Its Regulation of System A Amino Acid Uptake in Cultured Rat Vascular Smooth Muscle Cells
Circ. Res., December 1, 1996; 79(6): 1167 - 1176.
[Abstract] [Full Text]